<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04929951</url>
  </required_header>
  <id_info>
    <org_study_id>59461</org_study_id>
    <nct_id>NCT04929951</nct_id>
  </id_info>
  <brief_title>The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis</brief_title>
  <official_title>The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a non-surgical trial comparing the clinical and functional outcomes of patients with&#xD;
      osteoarthritis treated with Intra-articular injection of Micro Fragmented Adipose Tissue&#xD;
      versus conventional therapy of intra-articular injection of corticosteroid.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be a randomized controlled trial to compare outcomes between intra-articular&#xD;
      injection of Micro Fragmented Adipose Tissue and intra-articular injection of corticosteroid&#xD;
      in patients with mild to moderate osteoarthritis of the shoulder. Micro Fragmented Adipose&#xD;
      Tissue will be harvested at the subcutaneous tissue by lipoaspiration. Once fat tissue is&#xD;
      obtained, it will be processed with minimal manipulation in the clinic room.&#xD;
&#xD;
      To be considered for participation in this study, patients must have radiographic evidence of&#xD;
      mild to moderate osteoarthritis of the shoulder (glenohumeral joint). In addition, patients&#xD;
      must meet several inclusion/exclusion criteria to be randomized and included in this study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 7, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2025</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ASES Shoulder Score</measure>
    <time_frame>24 Months</time_frame>
    <description>Patient reported outcome measure that reports shoulder pain and shoulder functionality</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>DASH Outcome Measure</measure>
    <time_frame>24 Months</time_frame>
    <description>Patient reported questionnaire that measures physical function and symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Veterans RAND 12 (VR-12) score</measure>
    <time_frame>24 Months</time_frame>
    <description>Patient reported quality of life outcome measure on a scale of 0-50 with 50 being healthy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Osteoarthritis Shoulder</condition>
  <condition>Shoulder Pain</condition>
  <arm_group>
    <arm_group_label>MFAT (Micro Fragmented Adipose Tissue)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intra-articular shoulder injection of autologous Micro Fragmented Adipose Tissue harvested from the thigh using tumescent lipoaspiration and processing with minimal manipulation. This harvested tissue will then be injected into the patient's shoulder.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intra-articular injection of corticosteroid (Triamcinolone 40mg)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Micro Fragmented Adipose Tissue</intervention_name>
    <description>Harvesting of Micro Fragmented Adipose Tissue with intra-articular injection</description>
    <arm_group_label>MFAT (Micro Fragmented Adipose Tissue)</arm_group_label>
    <other_name>MFAT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Corticosteroid injection</intervention_name>
    <description>Sham harvesting of adipose tissue without intra-articular injection. Intra-articular injection of corticosteroid.</description>
    <arm_group_label>Conventional Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 25 and 75 years-old&#xD;
&#xD;
          -  Diagnosis of pre-existing osteoarthritis of the glenohumeral joint&#xD;
&#xD;
          -  Working understanding of the English language and able to fully understand the&#xD;
             procedure&#xD;
&#xD;
          -  Capable of providing informed consent&#xD;
&#xD;
          -  Able to complete online, in-person or phone surveys for the purposes of follow-up&#xD;
&#xD;
          -  Capable of understanding pre- and post-procedure care instructions&#xD;
&#xD;
          -  Ambulatory at baseline&#xD;
&#xD;
          -  Previous trial and failure of conservative therapy consisting of a minimum of 6 weeks&#xD;
             of physical therapy and trial of anti-inflammatory medications if not contraindicated,&#xD;
             with or without concomitant bracing and/or injections.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 25 or &gt; 75 years old&#xD;
&#xD;
          -  Radiographs demonstrating either no, little osteoarthritis, severe(bone on bone)&#xD;
             osteoarthritis&#xD;
&#xD;
          -  Prior total or partial joint replacement surgery or surgery involving cartilage&#xD;
             regeneration&#xD;
&#xD;
          -  Previous cortisone, PRP or Hyaluronic acid intra-articular injection within the last 3&#xD;
             months&#xD;
&#xD;
          -  Co-morbidity with the rheumatologic condition, inflammatory arthritis&#xD;
&#xD;
          -  Currently undergoing immunomodulatory therapy&#xD;
&#xD;
          -  Uncontrolled endocrine disorder&#xD;
&#xD;
          -  BMI &gt;40 or joint space not visible by ultrasound&#xD;
&#xD;
          -  Current diagnosis of osteomyelitis, human immunodeficiency virus (HIV-1, -2) and/or&#xD;
             hepatitis C (HCV), infection, and poorly controlled diabetes (HgA1C &gt;7.0)&#xD;
&#xD;
          -  Pregnancy or planned pregnancy&#xD;
&#xD;
          -  previous stem cell injection into treatment joint&#xD;
&#xD;
          -  Patient scheduled to undergo any concomitant shoulder surgical procedures or other&#xD;
             surgery which may affect outcomes.&#xD;
&#xD;
          -  Coagulopathy or anticoagulant treatment&#xD;
&#xD;
          -  Chronic pain involving multiple body parts or opioid medication management&#xD;
&#xD;
          -  Diagnosis of fibromyalgia&#xD;
&#xD;
          -  Concomitant massive(2 tendons with retraction), complete rotator cuff tendon tear&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Jessica N Nguyen, BS</last_name>
      <phone>650-723-0003</phone>
      <email>jessn16@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Eugene Y Roh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Geoffrey D Abrams, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 4, 2021</study_first_submitted>
  <study_first_submitted_qc>June 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2021</study_first_posted>
  <last_update_submitted>June 10, 2021</last_update_submitted>
  <last_update_submitted_qc>June 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Eugene Roh</investigator_full_name>
    <investigator_title>Clinical Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Shoulder Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

